A Troponin of 26.2: Ventricular Tachycardia Storm at the Marathon Finish Line
A 47-year-old highly active female with past medical history of rheumatoid arthritis (RA) presented with lightheadedness and diaphoresis after crossing the finish line at the local marathon.
View ArticleThe Findings: Navigating the SGLT2s Clinical Trials
Recent cardiovascular outcome trial results have led to the expansion of indications for SGLT2 inhibitors for patients with diabetes and atherosclerotic cardiovascular disease (ASCVD) and chronic...
View ArticleSymptomatic HCM: Diagnostic Challenge
A 47-year-old woman presents with increasingly frequent and progressive shortness of breath and chest tightness with activities such as climbing one flight of stairs.
View ArticleYoung Woman with Exertional Leg Pain
A 32-year-old woman with lower extremity claudication, sickle cell trait, depression, and history of intrauterine fetal demise presents to the vascular medicine clinic complaining bilateral lower...
View ArticleWhy is the Right Heart Big?
A 63-year-old woman with a history of atrial arrhythmia requiring ablation 10 years ago, presented with diverticulitis.
View ArticleTime to Run? Evaluation and Management of a College Athlete After COVID-19...
An 18-year old male cross-country runner with recent COVID-19 infection presented for a sports pre-participation evaluation.
View ArticleAthlete's Heart: More Than Just Muscle
Ms. S. is a 46-year-old female who initially presents to her local Emergency Department with 1 week of chest pain. She describes the pain as dull, achy, and substernal that is made worse with inspiration.
View ArticlePost-Acute Sequelae of SARS-CoV2 Infection in a Collegiate Athlete:...
A 21-year-old female collegiate track and field athlete with a history of exercise-induced asthma and acute COVID-19 infection 4 months prior is referred to a sports cardiologist for evaluation of...
View ArticleDeciphering SGLT2's: Mechanisms of Action and Resulting Indications
Recent cardiovascular outcome trial results have led to the expansion of indications for SGLT2 inhibitors for patients with diabetes and atherosclerotic cardiovascular disease (ASCVD) and chronic...
View ArticleManaging Atherosclerotic Cardiovascular Risk in Young Adults
The following are key points to remember from this state-of-the-art review on managing atherosclerotic cardiovascular risk in young adults.
View Article2022 ACC Decision Pathway on Cardiovascular Sequelae of COVID-19: Key Points
The following are key points to remember from the 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults including myocarditis and other myocardial involvement,...
View ArticleACC Issues Clinical Guidance on CV Consequences of COVID-19
A new Expert Consensus Decision Pathway released by the ACC addresses the evaluation and management of some of the more common cardiovascular sequelae in adults with COVID-19.
View ArticleACC.22 Research Explores Smartwatch Health Data, Noise Pollution, TikTok, More
Groundbreaking research exploring a wide range of topics including the efficacy of smartwatch health data, noise pollution as an additional risk factor for cardiovascular disease, health information...
View ArticleComparison of American and European Guidelines for CVD Prevention
The following are key points to remember from this review, which compares the most recent American and European guidelines for primary prevention of cardiovascular disease (CVD).
View Article2022 AHA/ACC/HFSA Heart Failure Guideline: Key Perspectives
The following are key perspectives from the 2022 American Heart Association (AHA)/American College of Cardiology (ACC)/Heart Failure Society of America (HFSA) Guideline for the Management of Heart...
View ArticleNew ACC, AHA, HFSA Guideline Updates Recommendations For Managing HF
"Patient-centric recommendations" to help clinicians prevent, diagnose and treat heart failure (HF) are the focus of a new clinical guideline released April 1 by the ACC, the American Heart...
View ArticleGet to Know Your Leaders | A Leader of Leaders: Get to Know ACC President...
Edward T. A. Fry, MD, FACC, steps into his new role as ACC's 71st president during ACC's annual Convocation ceremony closing out ACC.22.
View ArticleAssociation of Blood Pressure With Cognitive Decline, Dementia, and Mortality
Is long-term cumulative blood pressure (BP) exposure associated with subsequent cognitive decline, incident dementia, and all-cause mortality among cognitively healthy adults?
View Article